Investigation and application of new recombinant materials inducing periodontal tissue regeneration
诱导牙周组织再生的新型重组材料的研究及应用
基本信息
- 批准号:18592273
- 负责人:
- 金额:$ 2.44万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Research conducted in 2007 revealed that the optimal conditions for peptide to form hard tissues were 7.5-15mg/mL for peptide concentration and 7-14 days for time interval after peptide injection into the back skins of rats. In the tissue reaction to new付ype Emdogain[○!R], eosinophilic amorphous substances (EAS) and many mononuclear cells were observed about 7 days after injection of peptide into the rat backs, and on day 14 a small amount of EAS remained, mononuclear cells and fibroblasts were increased in number, and scattered eosinophils were observed. However, hard tissue formation was not confirmed. Ultrastructurally, some cells showed abundant rough endoplasmic reticulum, and the others many mitochondria. In studies of the effect of peptide on human periodontal ligament fibroblasts (HPdLF), alkaline phosphatase activity after 7 days of culture was increased 8-fold as compared with that after one day of culture. Total RNA was extracted 1 and 3 days after culture of HPdLF with 100mg/mL of peptide, and cDNA reverse transcription was carried out, followed by microarray analysis. On culture day 3, compared with on day 1, mRNA of bone morphogeneticprotein receptor type 1(BMPR1) Awas increased 34.18-fold, that of BAP41.97-fold, that of osteonectin 1.55-fold, and that of BMPR 1B 1.05-fold, but that of fibroblast growth factor receptor-like protein 1(FGFRL1) was reduced to 1/25. Thus, hard tissue formation was observed in the tissue reaction to peptide, BMPR 1A gene expression, which is associated with bone formation, was increased to a high level, and that of FGFRL1 was markedly reduced. These results might indicate that the peptide make HPdLF induce the hard tissue formation.
2007年的研究表明,多肽形成硬组织的最佳条件是多肽浓度为7.5-15 mg/mL,多肽注射到大鼠背部皮肤后间隔7-14天。在对新付[0!R]的组织反应中,大鼠背部注射多肽后7d左右可见嗜酸性无定形物质(EAS)和大量单核细胞,第14天仍有少量EAS残留,单核细胞和成纤维细胞增多,可见散在的嗜酸性粒细胞。然而,硬组织的形成还没有得到证实。超微结构上,有的细胞粗面内质网丰富,有的细胞线粒体较多。在多肽对人牙周膜成纤维细胞(HPdLF)影响的研究中,培养7d的碱性磷酸酶活性是培养1d的8倍。含100 mg/mL肽的HPdLF培养1天和3天后提取总RNA,进行cDNA逆转录后进行基因芯片分析。培养3d时,骨形态发生蛋白受体1型(BMPR1)A、BAP41.97、On-ectin、BMPR-1B的mRNA水平分别为第1天的34.18倍、41.97倍、1.55倍、1.05倍,而成纤维细胞生长因子受体样蛋白1(FGFRL1)的水平仅为1/25。因此,在多肽的组织反应中观察到了硬组织的形成,与骨形成相关的BMPR1a基因的表达增加到高水平,而FGFRL1的表达明显减少。这些结果可能表明,HPdLF能诱导硬组织的形成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Akio其他文献
TANAKA Akio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Akio', 18)}}的其他基金
Gene expression of periodontal ligament stem cells to human-derived amelogenin peptide
牙周膜干细胞对人源牙釉蛋白肽的基因表达
- 批准号:
16K11847 - 财政年份:2016
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effect of novel bone-forming agent on human periodontal ligament stem cells
新型成骨剂对人牙周膜干细胞的影响
- 批准号:
24593138 - 财政年份:2012
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel treatment targeting Hedgehog signal in oral cancer
针对口腔癌 Hedgehog 信号的新型治疗方法的开发
- 批准号:
22792008 - 财政年份:2010
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of anti-hard keratin antibody and expression mechanism analysis of shadow cell
抗硬角蛋白抗体的研制及影子细胞表达机制分析
- 批准号:
19791348 - 财政年份:2007
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Cell adhesion molecules and cytokines in periodontal disease
牙周病中的细胞粘附分子和细胞因子
- 批准号:
10307054 - 财政年份:1998
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Histochemical study of periodontitis in MRL/* mice with immunological disorder
免疫紊乱MRL/*小鼠牙周炎的组织化学研究
- 批准号:
03670859 - 财政年份:1991
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
NSF Engines: Piedmont Triad Regenerative Medicine Engine
NSF 引擎:Piedmont Triad 再生医学引擎
- 批准号:
2315654 - 财政年份:2024
- 资助金额:
$ 2.44万 - 项目类别:
Cooperative Agreement
I-Corps: Technology for processing lipoaspirate for plastic surgery and regenerative medicine
I-Corps:用于整形外科和再生医学的脂肪抽吸物处理技术
- 批准号:
2343782 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Standard Grant
Market Feasibility for a Engineering Biology Approach to Cell Therapy for Brain Cancer and Regenerative Medicine
脑癌和再生医学细胞治疗的工程生物学方法的市场可行性
- 批准号:
10074920 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant for R&D
Non-invasive assessment of 3D tissue constructs for regenerative medicine and cell transplantation
用于再生医学和细胞移植的 3D 组织结构的非侵入性评估
- 批准号:
23H03782 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel accelerated maturation method of hiPSC-derived cardiomyocytes: research for heart regenerative medicine
hiPSC 来源的心肌细胞的新型加速成熟方法的开发:心脏再生医学研究
- 批准号:
23K08265 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Animal Free Structured Collagens for Regenerative Medicine
用于再生医学的无动物源结构化胶原蛋白
- 批准号:
10076142 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant for R&D
Clickable Extracellular Vesicles to Silk-Based Biomaterials for Regenerative Medicine
用于再生医学的可点击细胞外囊泡到丝基生物材料
- 批准号:
10642420 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program
转化非人类灵长类再生医学和基因治疗/基因组编辑资源计划
- 批准号:
10889393 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Establishment of basic technology for the development of veterinary regenerative medicine products using clinically applicable canine iPS cells
建立利用临床适用的犬iPS细胞开发兽用再生医学产品的基础技术
- 批准号:
23H02388 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regenerative Medicine Research on Osteo-related Tissues of Spondylo-Dysplastic Ehlers–Danlos Syndrome Type 3 (EDSSPD3) with a point mutation of SLC39A13 Zinc Transporter Gene
埃勒斯脊柱发育不良骨相关组织的再生医学研究
- 批准号:
23K06510 - 财政年份:2023
- 资助金额:
$ 2.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




